| Excerpt | Relevance | Reference |
|---|
| "The aim of this prospective, double-blind, randomized, placebo-controlled study was to evaluate the efficacy of cilostazol, a selective phosphodiesterase 3 inhibitor, in patients with chronic tinnitus." | 9.22 | Effect of a 4-Week Treatment with Cilostazol in Patients with Chronic Tinnitus: A Randomized, Prospective, Placebo-controlled, Double-blind, Pilot Study. ( Baek, S; Chung, JW; Kang, WS; Kim, TS; Lim, HW; Song, CI, 2016) |
| "The aim of this prospective, double-blind, randomized, placebo-controlled study was to evaluate the efficacy of cilostazol, a selective phosphodiesterase 3 inhibitor, in patients with chronic tinnitus." | 5.22 | Effect of a 4-Week Treatment with Cilostazol in Patients with Chronic Tinnitus: A Randomized, Prospective, Placebo-controlled, Double-blind, Pilot Study. ( Baek, S; Chung, JW; Kang, WS; Kim, TS; Lim, HW; Song, CI, 2016) |